Fingerprint
Dive into the research topics of 'A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
Geoffrey L. Uy, Michael P. Rettig, Ibraheem H. Motabi, Kyle McFarland, Kathryn M. Trinkaus, Lindsay M. Hladnik, Shashikant Kulkarni, Camille N. Abboud, Amanda F. Cashen, Keith E. Stockerl-Goldstein, Ravi Vij, Peter Westervelt, John F. DiPersio
Research output: Contribution to journal › Article › peer-review
329
Scopus
citations